Description
Ipralin® HFA Inhaler is a combination bronchodilator designed for the management of Chronic Obstructive Pulmonary Disease (COPD), including chronic bronchitis and emphysema. Each metered dose delivers Ipratropium Bromide (20 mcg), an anticholinergic agent, and Salbutamol Sulfate (100 mcg), a short-acting β₂-adrenergic agonist. This dual-action formulation provides rapid and sustained relief from bronchospasm by targeting different pathways to relax airway muscles and improve airflow.
.webp)
 4ML.jpg)
.jpeg)
.webp)
.webp)
.jpeg)
 1000 MG.jpg)
Change Language